SGPSpyGlass Pharma, Inc.vs its industry peers
A metric-by-metric comparison of SpyGlass Pharma, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGP본 종목 | $963M#8 | — | 4.1x#7 | — | — | -36.7%#11 | — | -17.2%#7 | — | — | — | — |
| ATEC | $1.7B#1 | — | — | 2.2x#5 | 25.0%#5 | 11.6%#6 | -10.7%#5 | — | -18.5%#4 | 6#3 | -28.8%#9 | — |
| KMTS | $1.5B#2 | — | 6.7x#10 | 15.6x#12 | 59.0%#2 | -15.6%#9 | -141.6%#12 | -59.2%#11 | -59.5%#7 | 4#7 | 7.5%#7 | — |
| IART | $1.3B#3 | — | 1.2x#1 | 0.8x#1 | 1.5%#12 | -7389.9%#13 | -30.2%#9 | -49.5%#10 | -32.1%#6 | 6#3 | 8.8%#6 | — |
| AORT | $1.2B#4 | — | 2.8x#3 | 2.8x#6 | 13.6%#8 | 173.1%#1 | 7.6%#3 | 2.2%#4 | 3.0%#1 | 5#6 | -35.8%#10 | 0.3%#2 |
| TNDM | $1.2B#5 | — | 9.3x#11 | 1.2x#2 | 7.9%#11 | -113.2%#12 | -18.5%#8 | -157.0%#12 | -26.3%#5 | 3#9 | 39.8%#3 | — |
| PRCT | $1.1B#6 | — | 3.4x#4 | 3.7x#7 | 37.2%#4 | -4.5%#7 | -33.7%#10 | -0.0%#5 | -63.4%#8 | 2#10 | -49.7%#11 | — |
| IRMD | $1.1B#7 | 46.4x#2 | 10.4x#12 | 12.7x#11 | 14.4%#7 | 16.9%#4 | 31.2%#1 | 22.1%#1 | — | — | 17.6%#5 | 1.4%#1 |
| BBNX | $931M#9 | — | 3.6x#5 | 9.3x#10 | 53.9%#3 | -33.7%#10 | -71.5%#11 | -28.6%#9 | — | — | -11.1%#8 | — |
| SIBN | $840M#10 | — | 4.6x#8 | 4.2x#8 | 20.2%#6 | 38.8%#3 | -11.1%#6 | -10.4%#6 | -12.0%#2 | 6#3 | 24.2%#4 | — |
| ANGO | $650M#11 | — | 3.8x#6 | 2.0x#4 | 9.5%#10 | -8.1%#8 | -12.5%#7 | -21.5%#8 | -16.5%#3 | 4#7 | 50.0%#1 | — |
| DCTH | $570M#12 | 821.5x#3 | 4.7x#9 | 6.7x#9 | 129.1%#1 | 110.2%#2 | 0.8%#4 | 2.2%#3 | — | 8#1 | 48.9%#2 | — |
| TCMD | $514M#13 | 21.2x#1 | 2.3x#2 | 1.6x#3 | 12.5%#9 | 12.5%#5 | 8.9%#2 | 8.5%#2 | — | 8#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice